{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:19:05Z","timestamp":1791350345162,"version":"4.3.1"},"reference-count":158,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":2209,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.bbadis.2007.04.009","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T11:04:39Z","timestamp":1178708679000},"page":"718-736","source":"Crossref","is-referenced-by-count":271,"title":["Oxidized phospholipids: From molecular properties to disease"],"prefix":"10.1016","volume":"1772","author":[{"given":"Gilbert O.","family":"Fruhwirth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Loidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albin","family":"Hermetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2007.04.009_bib1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1021\/tx050247f","article-title":"Identification of oxidatively truncated ethanolamine phospholipids in retina and their generation from polyunsaturated phosphatidylethanolamines","volume":"19","author":"Gugiu","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbalip.2005.08.011","article-title":"The presence of oxidized phosphatidylserine on Fas-mediated apoptotic cell surface","volume":"1736","author":"Matsura","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) \u2014 Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbadis.2007.04.009_bib3","doi-asserted-by":"crossref","first-page":"25189","DOI":"10.1074\/jbc.274.36.25189","article-title":"Biologically active oxidized phospholipids","volume":"274","author":"McIntyre","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib4","series-title":"Food Lipids \u2014 Chemistry, Nutrition, and Biotechnology, Food Science in Technology","first-page":"283","article-title":"Lipid Oxidation of Edible Oil","author":"Min","year":"1997"},{"key":"10.1016\/j.bbadis.2007.04.009_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1196\/annals.1333.042","article-title":"Is atherosclerosis a multifactorial disease or is it induced by a sequence of lipid peroxidation reactions?","volume":"1043","author":"Spiteller","year":"2005","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2007.04.009_bib6","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1074\/jbc.M507340200","article-title":"Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases","volume":"281","author":"Stafforini","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.ATV.0000051407.42536.73","article-title":"Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions","volume":"23","author":"Hoff","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib8","doi-asserted-by":"crossref","first-page":"38503","DOI":"10.1074\/jbc.M203318200","article-title":"Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36","volume":"277","author":"Podrez","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0098-2997(03)00009-8","article-title":"Basic aspects of the biochemical reactivity of 4-hydroxynonenal","volume":"24","author":"Schaur","year":"2003","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bbadis.2007.04.009_bib10","doi-asserted-by":"crossref","first-page":"31298","DOI":"10.1074\/jbc.M604039200","article-title":"Phospholipid hydroxyalkenals, a subset of recently discovered endogenous CD36 ligands, spontaneously generate novel furan-containing phospholipids lacking CD36 binding activity in vivo","volume":"281","author":"Gao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib11","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1073\/pnas.89.22.10721","article-title":"Non-cyclooxygenase-derived prostanoids (F2-Isoprostanes) are formed in situ on phospholipids","volume":"89","author":"Morrow","year":"1992","journal-title":"PNAS"},{"key":"10.1016\/j.bbadis.2007.04.009_bib12","series-title":"Goodman's and Gilman's The pharmacological Basis of Therapeutics","first-page":"669","article-title":"Lipid-Derived Autocoids: Eicosanoids and Platelet Activating Factor","author":"Morrow","year":"2001"},{"key":"10.1016\/j.bbadis.2007.04.009_bib13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0891-5849(97)00133-0","article-title":"Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat","volume":"23","author":"Waugh","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2007.04.009_bib14","first-page":"157","article-title":"Separation and identification of F2-isoprostane regioisomers and diastereomers by novel liquid chromatographic\/mass spectrometric methods","volume":"827","author":"Yin","year":"2005","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.bbadis.2007.04.009_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0006-2952(02)01607-6","article-title":"Antioxidant significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes","volume":"65","author":"Montine","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib16","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1074\/jbc.274.16.10863","article-title":"Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway","volume":"274","author":"Chen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib17","doi-asserted-by":"crossref","first-page":"25178","DOI":"10.1074\/jbc.M502891200","article-title":"Identification of the major urinary metabolite of the highly reactive cyclopentenone isoprostane 15-A2t-Isoprostane in vivo","volume":"280","author":"Milne","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0891-5849(89)90102-0","article-title":"Oxygen radical chemistry of polyunsaturated fatty acids","volume":"7","author":"Gardner","year":"1989","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2007.04.009_bib19","doi-asserted-by":"crossref","first-page":"24787","DOI":"10.1074\/jbc.274.35.24787","article-title":"Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein","volume":"274","author":"Watson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib20","doi-asserted-by":"crossref","first-page":"28479","DOI":"10.1074\/jbc.M303984200","article-title":"Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase","volume":"278","author":"Gao","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib21","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1021\/ja00332a049","article-title":"Solvent-induced fragmentation of prostaglandin endoperoxides. New aldehyde products from PGH2 and a novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution","volume":"106","author":"Salomon","year":"1984","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2007.04.009_bib22","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/tx970016b","article-title":"Oxidation of low-density lipoproteins produces levuglandin-protein adducts","volume":"10","author":"Salomon","year":"1997","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib23","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1021\/bi990470+","article-title":"Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway","volume":"38","author":"Boutaud","year":"1999","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.bbadis.2007.04.009_bib24","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1021\/jo00099a039","article-title":"Generation of pyrroles in the reaction of Levuglandin E2 with proteins","volume":"59","author":"Iyer","year":"1994","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib25","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1074\/jbc.274.19.13139","article-title":"Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts","volume":"274","author":"Brame","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/tx034185+","article-title":"Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro","volume":"17","author":"Poliakov","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/249066a0","article-title":"Animal longevity and protein turnover rate","volume":"249","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2007.04.009_bib28","doi-asserted-by":"crossref","first-page":"28395","DOI":"10.1074\/jbc.274.40.28395","article-title":"Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines","volume":"274","author":"Marathe","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib29","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1074\/jbc.M100878200","article-title":"Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor ligands and agonists","volume":"276","author":"Davies","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0022-2275(20)32404-4","article-title":"Structural characterization of oxidized phospholipid products derived from arachidonate-containing plasmenyl glycerophosphocholine","volume":"41","author":"Khaselev","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0009-3084(96)02578-9","article-title":"Curvature stress and polymorphism in membranes","volume":"81","author":"Janes","year":"1996","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbadis.2007.04.009_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1388-1981(00)00084-6","article-title":"Oxidation of unsaturated phospholipids in membrane bilayer mixtures is accompanied by membrane fluidity changes","volume":"1487","author":"Borst","year":"2000","journal-title":"Biochim. Biophys. Acta (BBA) \u2014 Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbadis.2007.04.009_bib33","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.1021\/bi00028a022","article-title":"Quantitative analysis of lipid\u2013lipid and lipid\u2013protein interactions in membranes by use of pyrene-labeled phosphoinositides","volume":"34","author":"Pap","year":"1995","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.bbadis.2007.04.009_bib34","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1016\/j.febslet.2005.07.022","article-title":"Oxidized phospholipids induce phase separation in lipid vesicles","volume":"579","author":"Megli","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2007.04.009_bib35","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1529\/biophysj.105.080176","article-title":"Characterization of two oxidatively modified phospholipids in mixed monolayers with DPPC","volume":"90","author":"Sabatini","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbadis.2007.04.009_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-5793(03)00861-5","article-title":"Respiration state IV-generated ROS destroy the mitochondrial bilayer packing order in vitro. An EPR study","volume":"550","author":"Megli","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2007.04.009_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.febslet.2004.07.057","article-title":"Mitochondrial phospholipid bilayer structure is ruined after liver oxidative injury in vivo","volume":"573","author":"Megli","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2007.04.009_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0009-3084(91)90087-R","article-title":"On the principles of functional ordering in biological membranes","volume":"57","author":"Kinnunen","year":"1991","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbadis.2007.04.009_bib39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000016360","article-title":"Lipid bilayers as osmotic response elements","volume":"10","author":"Kinnunen","year":"2000","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0898-6568(02)00144-4","article-title":"Phospholipase A2 isoforms: a perspective","volume":"15","author":"Chakraborti","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2007.04.009_bib41","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.bbalip.2006.06.017","article-title":"Clinical aspects of plasma platelet-activating factor-acetylhydrolase","volume":"1761","author":"Karasawa","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA) \u2014 Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbadis.2007.04.009_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-5793(03)01007-X","article-title":"Mildly oxidised LDL induces more macrophage death than moderately oxidised LDL: roles of peroxidation, lipoprotein-associated phospholipase A2 and PPAR\u03b1","volume":"553","author":"Carpenter","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2007.04.009_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0014-5793(01)02840-X","article-title":"Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages","volume":"505","author":"Carpenter","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2007.04.009_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0021-9150(00)80754-6","article-title":"Anti-atherosclerotic effect of SB-244323, a lipoprotein associated phospholipase A2 inhibitor, in WHHL rabbits","volume":"151","author":"Benson","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2007.04.009_bib45","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.atherosclerosis.2006.02.016","article-title":"The epidemiology of Lp-PLA2: distribution and correlation with cardiovascular risk factors in a population-based cohort","volume":"190","author":"Persson","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2007.04.009_bib46","doi-asserted-by":"crossref","first-page":"32315","DOI":"10.1074\/jbc.272.51.32315","article-title":"Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II","volume":"272","author":"Matsuzawa","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib47","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.bbalip.2006.06.001","article-title":"The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells","volume":"1761","author":"Fruhwirth","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2007.04.009_bib48","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.ATV.20.10.2248","article-title":"Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the sn-2 position","volume":"20","author":"Subbanagounder","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2007.04.009_bib50","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s11745-003-1109-6","article-title":"Phospholipid hydroperoxides are detoxified by phospholipase A2 and GSH peroxidase in rat gastric mucosa","volume":"38","author":"Miyamoto","year":"2003","journal-title":"Lipids"},{"key":"10.1016\/j.bbadis.2007.04.009_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/0264-6021:3620051","article-title":"Induction of glutathione synthesis by oxidized low-density lipoprotein and 1-palmitoyl-2-arachidonoyl phosphatidylcholine: protection against quinone-mediated oxidative stress","volume":"362","author":"Moellering","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2007.04.009_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0021-9150(99)00486-4","article-title":"Overexpression of PHGPx inhibits hydroperoxide-induced oxidation, NF\u03baB activation and apoptosis and affects oxLDL-mediated proliferation of rabbit aortic smooth muscle cells","volume":"152","author":"Brigelius-Floh\u00e9","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2007.04.009_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0891-5849(02)01197-8","article-title":"Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells","volume":"34","author":"Imai","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2007.04.009_bib54","first-page":"178","article-title":"Prevention of geranylgeranoic acid-induced apoptosis by phospholipid hydroperoxide glutathione peroxidase gene","author":"Shidoji","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib55","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0009-2797(00)00299-4","article-title":"Involvement of aldose reductase in the metabolism of atherogenic aldehydes","volume":"130\u2013132","author":"Srivastava","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2007.04.009_bib56","doi-asserted-by":"crossref","first-page":"53395","DOI":"10.1074\/jbc.M403416200","article-title":"Aldose reductase-catalysed reduction of aldehyde phospholipids","volume":"279","author":"Srivastava","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/tx00043a004","article-title":"Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydoxy-2-nonenal in the rat","volume":"8","author":"Alary","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib58","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1021\/tx970112c","article-title":"(Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins","volume":"10","author":"Kaur","year":"1997","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/tx000007u","article-title":"HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques","volume":"13","author":"Salomon","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib60","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0891-5849(98)00149-X","article-title":"Covalent modifications of aminophospholipids by 4-hydroxynonenal","volume":"25","author":"Guichardant","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2007.04.009_bib61","first-page":"261","article-title":"Detection of 1,N-2-propanedeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon-tetrachloride in F344 rats","volume":"130","author":"Wacker","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2007.04.009_bib62","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/carcin\/19.5.939","article-title":"2,3-Epoxy-4-hydroxynonenal, a potential lipid peroxidation product for etheno adduct formation, is not a substrate of human epoxide hydrolase","volume":"19","author":"Chen","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2007.04.009_bib63","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0090-6980(89)90096-8","article-title":"Levuglandin E2 crosslinks proteins","volume":"37","author":"Iyer","year":"1989","journal-title":"Prostaglandins"},{"key":"10.1016\/j.bbadis.2007.04.009_bib64","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1471-4159.2002.01064.x","article-title":"Prostaglandin H2 (PGH2) accelerates formation of amyloid beta1\u201342 oligomers","volume":"82","author":"Boutaud","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib65","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1096\/fj.01-0696fje","article-title":"Effects of reactive {gamma}-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function","volume":"16","author":"Davies","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2007.04.009_bib66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat. Immun."},{"key":"10.1016\/j.bbadis.2007.04.009_bib67","doi-asserted-by":"crossref","first-page":"29661","DOI":"10.1074\/jbc.M300738200","article-title":"Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8: a role for toll-like receptor 4 and a glycophosphatidylinositol-anchored protein","volume":"278","author":"Walton","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib68","doi-asserted-by":"crossref","first-page":"13043","DOI":"10.1073\/pnas.192399699","article-title":"C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids","volume":"99","author":"Chang","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.bbadis.2007.04.009_bib69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nature01023","article-title":"Protective role for phospholipid oxidation products in endotoxin-induced tissue damage","volume":"419","author":"Bochkov","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2007.04.009_bib70","doi-asserted-by":"crossref","first-page":"16221","DOI":"10.1074\/jbc.270.27.16221","article-title":"The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids","volume":"270","author":"Rigotti","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib71","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2006.06.007","article-title":"A CD36-dependent signaling cascade is necessary for macrophage foam cell formation","volume":"4","author":"Rahaman","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2007.04.009_bib72","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI9259","article-title":"Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice","volume":"105","author":"Febbraio","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2007.04.009_bib73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/01.ATV.15.2.269","article-title":"Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines: evidence implicating the lipid moiety of the lipoprotein as the binding site","volume":"15","author":"Nicholson","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib74","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI8574","article-title":"Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species","volume":"105","author":"Podrez","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2007.04.009_bib75","series-title":"Glycoprotein IV Mediates Thrombospondin-Dependent Platelet-Monocyte and Platelet-U937 Cell Adhesion","first-page":"546","author":"Silverstein","year":"1989"},{"key":"10.1016\/j.bbadis.2007.04.009_bib76","series-title":"CD36 and Atherosclerosis","first-page":"483","author":"Silverstein","year":"2000"},{"key":"10.1016\/j.bbadis.2007.04.009_bib77","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1074\/jbc.274.5.3048","article-title":"Phosphatidylserine receptors: role of CD36 in binding of anionic phospholipid vesicles to monocytic cells","volume":"274","author":"Tait","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1388-1981(99)00137-7","article-title":"Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm","volume":"1441","author":"Abumrad","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2007.04.009_bib79","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/01.ATV.16.8.1033","article-title":"Identification on human CD36 of a domain (155\u2013183) implicated in binding oxidized low-density lipoproteins (Ox-LDL)","volume":"16","author":"Navazo","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib80","doi-asserted-by":"crossref","first-page":"34875","DOI":"10.1074\/jbc.273.52.34875","article-title":"Recombinant glutathione S-transferase\/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain","volume":"273","author":"Pearce","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib81","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0049-3848(99)00179-6","article-title":"PS-liposome and ox-LDL bind to different sites of the immunodominant domain (#155\u2013183) of CD36: a study with GS95, a new anti-CD36 monoclonal antibody","volume":"97","author":"Yamaguchi","year":"2000","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib82","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0891-5849(02)01294-7","article-title":"Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor","volume":"34","author":"Podrez","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2007.04.009_bib83","doi-asserted-by":"crossref","first-page":"38517","DOI":"10.1074\/jbc.M205924200","article-title":"A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions","volume":"277","author":"Podrez","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib84","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1189\/jlb.0304127","article-title":"Endogenous ligands of Toll-like receptors","volume":"76","author":"Tsan","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib85","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor 4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2007.04.009_bib86","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.ATV.0000079340.80744.B8","article-title":"Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2","volume":"23","author":"Walton","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib87","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2005.11.015","article-title":"Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages: implications in atherosclerosis","volume":"188","author":"Pegorier","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2007.04.009_bib88","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.ATV.15.11.2019","article-title":"Stimulation of Gs and inhibition of Gi protein functions by minimally oxidized LDL","volume":"15","author":"Parhami","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib89","doi-asserted-by":"crossref","first-page":"40676","DOI":"10.1074\/jbc.M507787200","article-title":"Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G Protein-coupled receptor G2A","volume":"280","author":"Obinata","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib90","doi-asserted-by":"crossref","first-page":"12334","DOI":"10.1073\/pnas.95.21.12334","article-title":"A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2\/M","volume":"95","author":"Weng","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.bbadis.2007.04.009_bib91","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/01.RES.0000207394.39249.fc","article-title":"Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC","volume":"98","author":"Li","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib92","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00041433-199710000-00009","article-title":"Cell-mediated immunity in atherosclerosis","volume":"8","author":"Hansson","year":"1997","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib93","series-title":"Molecular Basis of Cardiovascular Disease","first-page":"349","article-title":"Atherogenesis and Inflammation","author":"Libby","year":"1999"},{"key":"10.1016\/j.bbadis.2007.04.009_bib94","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/clim.1998.4682","article-title":"Are immunological mechanisms relevant for the development of atherosclerosis?","volume":"90","author":"Witztum","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib95","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1161\/01.CIR.96.11.4095","article-title":"Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research","volume":"96","author":"Libby","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2007.04.009_bib96","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/01.ATV.15.5.571","article-title":"Immunological evidence for the presence of advanced glycosylation end products in atheroslcerotic lesions of euglycemic rabbits","volume":"15","author":"Palinski","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib97","doi-asserted-by":"crossref","first-page":"S449","DOI":"10.1016\/S0002-8703(99)70272-3","article-title":"Autoimmunity and atherosclerosis","volume":"138","author":"Wick","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.bbadis.2007.04.009_bib98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid\u2013protein adducts inhibit macrophage uptake of oxidized low density lipoproteins","volume":"103","author":"H\u00f6rkk\u00f6","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2007.04.009_bib99","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1172\/JCI118854","article-title":"Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein","volume":"98","author":"H\u00f6rkk\u00f6","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2007.04.009_bib100","doi-asserted-by":"crossref","first-page":"10361","DOI":"10.1073\/pnas.94.19.10356","article-title":"The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)","volume":"94","author":"H\u00f6rkko","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2007.04.009_bib101","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.96.11.6353","article-title":"Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition","volume":"96","author":"Chang","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.bbadis.2007.04.009_bib102","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1050-1738(01)00098-6","article-title":"Evidence for a role of phospholipid oxidation products in atherogenesis","volume":"11","author":"Berliner","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbadis.2007.04.009_bib103","doi-asserted-by":"crossref","first-page":"12010","DOI":"10.1073\/pnas.96.21.12010","article-title":"Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils","volume":"96","author":"Leitinger","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.bbadis.2007.04.009_bib104","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI5710","article-title":"Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta 1 integrin","volume":"103","author":"Shih","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2007.04.009_bib105","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/01.ATV.0000081215.45714.71","article-title":"Oxidized phospholipid-induced endothelial cell\/monocyte interaction is mediated by a cAMP-dependent R-Ras\/PI3-kinase pathway","volume":"23","author":"Cole","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib106","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00041433-200208000-00003","article-title":"Oxidized lipids as mediators of coronary heart disease","volume":"13","author":"Navab","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib107","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V99.1.199","article-title":"Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK\/EGR-1 and Ca+\/NFAT","volume":"99","author":"Bochkov","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2007.04.009_bib108","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/01.ATV.0000252842.57585.df","article-title":"Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids","volume":"27","author":"Zimman","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib109","doi-asserted-by":"crossref","first-page":"17030","DOI":"10.1074\/jbc.M011663200","article-title":"Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells","volume":"276","author":"Reddy","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1537-1891(02)00171-4","article-title":"Identification of genes induced by oxidized phospholipids in human aortic endothelial cells","volume":"38","author":"Reddy","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib111","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1194\/jlr.M500555-JLR200","article-title":"Specific monocyte adhesion to endothelial cells induced b oxidized phospholipids involves activation of cPLA2 and lipoxygenase","volume":"47","author":"Huber","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib112","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/hh0701.088838","article-title":"Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and plateletderived growth factor in vascular endothelial and smooth muscle cells","volume":"88","author":"Patricia","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib113","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.RES.87.6.516","article-title":"Role for peroxisome proliferator-activated receptor {alpha} in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells","volume":"87","author":"Lee","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib114","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1074\/jbc.M107602200","article-title":"Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis","volume":"277","author":"Subbanagounder","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib115","doi-asserted-by":"crossref","first-page":"30175","DOI":"10.1074\/jbc.M312198200","article-title":"Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src\/signal transducers and activators of transcription (STAT)3 pathway","volume":"279","author":"Yeh","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib116","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/hq1001.097027","article-title":"Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-{alpha} and oxidized phospholipids","volume":"21","author":"Yeh","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib117","first-page":"768","article-title":"High-Density Lipoprotein Modulates Oxidized Phospholipid Signaling in Human Endothelial Cells From Proinflammatory to Anti-inflammatory","volume":"21","author":"Gharavi","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib118","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/01.RES.0000215343.89308.93","article-title":"Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids","volume":"98","author":"Gharavi","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib119","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2005.08.072","article-title":"Lipid peroxidation: mechanisms, inhibition, and biological effects","volume":"338","author":"Niki","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2007.04.009_bib120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1537-1891(02)00170-2","article-title":"Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells","volume":"38","author":"Subbanagounder","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib121","doi-asserted-by":"crossref","first-page":"L808","DOI":"10.1152\/ajplung.00220.2003","article-title":"Inhibition of LPS- and CpG DNA-induced TNFa response by oxidized phospholipids","volume":"286","author":"Ma","year":"2004","journal-title":"Am. J. Physiol., Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib122","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1194\/jlr.M600060-JLR200","article-title":"A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products","volume":"47","author":"Walton","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib123","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1537-1891(02)00172-6","article-title":"Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS","volume":"38","author":"Kadl","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib124","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.ATV.0000016153.47693.B2","article-title":"Molecular events in acute inflammation","volume":"22","author":"Prescott","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib125","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1172\/JCI118288","article-title":"Oxidatively modified LDL contains phospholipids with PAF-like activity and stimulates the growth of smooth muscle cells","volume":"96","author":"Heery","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2007.04.009_bib126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1537-1891(02)00169-6","article-title":"Activation of vascular cells by PAF-like lipids in oxidized LDL","volume":"38","author":"Marathe","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib127","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1074\/jbc.M109546200","article-title":"Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor \u00c6 and oxidized alkyl phospholipids from oxidized low density lipoprotein","volume":"277","author":"Ponstler","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib128","doi-asserted-by":"crossref","first-page":"12741","DOI":"10.1073\/pnas.0605457103","article-title":"Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids","volume":"103","author":"Gargalovic","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.bbadis.2007.04.009_bib129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00041433-200110000-00009","article-title":"Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation","volume":"12","author":"Martinet","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nm0298-222","article-title":"Inhibition of neointimal cell Bcl-x expression induces apoptosis and regression of vascular disease","volume":"4","author":"Pollman","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2007.04.009_bib131","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.CIR.99.9.1236","article-title":"Regression of atherosclerosis: role of nitric oxide and apoptosis","volume":"99","author":"Wang","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2007.04.009_bib132","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/01.ATV.18.10.1519","article-title":"Apoptosis in atherosclerotic plaques. Quantitative and qualitative aspects","volume":"18","author":"Kockx","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib133","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.1997.tb51996.x","article-title":"Molecular determinants of atherosclerotic plaque vulnerability","volume":"811","author":"Libby","year":"1997","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2007.04.009_bib134","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/hq0102.101525","article-title":"Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte\u2013endothelial interactions","volume":"22","author":"Huber","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib135","doi-asserted-by":"crossref","first-page":"19965","DOI":"10.1074\/jbc.M204513200","article-title":"NADPH oxidase-dependent oxidation and externalization of phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells. Role in phagocytic clearance","volume":"277","author":"Arroyo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(00)01707-5","article-title":"Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis","volume":"477","author":"Kagan","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2007.04.009_bib137","doi-asserted-by":"crossref","first-page":"15168","DOI":"10.1016\/S0021-9258(18)42161-8","article-title":"Novel leukocyte agonists are released by endothelial cells exposed to peroxide","volume":"267","author":"Patel","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib138","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20031763","article-title":"Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory","volume":"200","author":"Chang","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2007.04.009_bib139","doi-asserted-by":"crossref","first-page":"32921","DOI":"10.1074\/jbc.M306088200","article-title":"Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells","volume":"278","author":"Loidl","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/biof.5520130106","article-title":"Platelet-derived factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis","volume":"13","author":"Tokumura","year":"2000","journal-title":"BioFactors"},{"key":"10.1016\/j.bbadis.2007.04.009_bib141","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0009-3084(03)00091-4","article-title":"Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophosphatidylcholine","volume":"126","author":"Kogure","year":"2003","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbadis.2007.04.009_bib142","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0090-6980(02)00010-2","article-title":"Arachidonic acid-derived oxidation products initiate apoptosis in vascular smooth muscle cells","volume":"70","author":"Kalyankrishna","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbadis.2007.04.009_bib143","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1194\/jlr.M600394-JLR200","article-title":"Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells","volume":"48","author":"Moumtzi","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib144","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/abio.2001.5075","article-title":"Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography","volume":"292","author":"Waddington","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib145","doi-asserted-by":"crossref","first-page":"13597","DOI":"10.1074\/jbc.272.21.13597","article-title":"Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte\/endothelial interactions and evidence for their presence in vivo","volume":"272","author":"Watson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib146","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1172\/JCI119735","article-title":"Localization of distinct F2-isoprostanes in human atherosclerotic lesions","volume":"100","author":"Pratico","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2007.04.009_bib147","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1161\/01.ATV.17.11.3236","article-title":"Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions","volume":"17","author":"Gniwotta","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2007.04.009_bib148","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1388-1981(00)00038-X","article-title":"Isolevuglandin\u2013protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway","volume":"1485","author":"Salomon","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2007.04.009_bib149","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.0000245485.04489.ee","article-title":"Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions","volume":"99","author":"Bochkov","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/B:GLYC.0000033629.54962.68","article-title":"Identification of a biologically active component in minimally oxidized low density lipoprotein (MM-LDL) responsible for aortic smooth muscle cell proliferation","volume":"20","author":"Chatterjee","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbadis.2007.04.009_bib151","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.RES.0000147310.18962.06","article-title":"Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac","volume":"95","author":"Birukov","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib152","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0008-6363(02)00437-6","article-title":"Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kB\/IkB and ERK2 dependent mechanisms","volume":"55","author":"Eligini","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib153","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.RES.0000146030.53089.18","article-title":"Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products","volume":"95","author":"Yeh","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib154","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mvr.2003.09.004","article-title":"Signal transduction pathways activated in human pulmonary endothelial cells by OxPAPC, a bioactive component of oxidized lipoproteins","volume":"67","author":"Birukov","year":"2004","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.bbadis.2007.04.009_bib155","doi-asserted-by":"crossref","first-page":"51006","DOI":"10.1074\/jbc.M304103200","article-title":"Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein","volume":"278","author":"Kr\u00f6nke","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2007.04.009_bib156","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1182\/blood-2002-08-2428","volume":"101","author":"Ishii","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2007.04.009_bib157","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09533710022149368","article-title":"Regulation of platelet adhesion by oxidized lipoproteins and oxidized phospholipids","volume":"13","author":"Hartwich","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.bbadis.2007.04.009_bib158","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/01.ATV.0000153106.03644.a0","article-title":"Oxidized phospholipids trigger atherogenic inflammation in murine arteries","volume":"25","author":"Furnkranz","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443907001032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443907001032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T06:44:20Z","timestamp":1628837060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443907001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":158,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0925443907001032"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2007.04.009","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}